Asymmetrically PEGylated and amphipathic heptamethine indocyanine dyes potentiate radiotherapy of renal cell carcinoma via mitochondrial targeting Authors: Zifei Wu, Xie Huang, Chuan Wu, Yan Zhou, Mingquan Gao, Shenglin Luo, Qiang Xiang, Weidong Wang, Rong Li Published: 2024 ABSTRACT Enhancing the sensitivity of radiotherapy (RT) towards renal cell carcinoma (RCC) remains a challenge because RCC is a radioresistant tumor. In this work, we design and report asymmetrically Polyethylene Glycol (PEG)ylated and amphipathic heptamethine indocyanine dyes for efficient radiosensitization of RCC treatment. They were synthesized by modifying different lengths of PEG chains as hydrophilic moieties on one N-alkyl chain of a mitochondria-targeting heptamethine indocyanine dye (IR-808), and a radiosensitizer 2-nitroimidazole (NM) as a hydrophobic moiety on another N-alkyl chain. The PEG modification significantly improved water solubility, decreased the intermolecular π–π large aggregates, thereby enhanced renal excretion. The asymmetrical and amphipathic modification enhanced the preferential accumulation in renal tumors through self-assembly into small-size nanoparticles in aqueous environment. Radiosensitization was further improved by preferential accumulation in renal tumor cells and their mitochondria as mitochondria play a crucial role in rapid cancer cell growth, metastasis, and RT resistance. Additionally, the modification also increased the abilities of fluorescence emission and photostability, which is meaningful for imaging-guided precise RCC RT. Therefore, our findings may present a theranostic radiosensitizer for renal tumor-targeted imaging and radiosensitization.Graphical Abstract Supplementary InformationThe online version contains supplementary material available at 10.1186/s12951-024-03012-3. Introduction Globally, renal cell carcinoma (RCC) affects nearly 300,000 individuals annually, resulting in over 100,000 deaths each year. Radiotherapy (RT) is the mainstay treatment for patients with RCC, particularly those ineligible for surgery. However, RCC is a radioresistant tumor that requires a continuous high dosage of radiation exposure, inevitably increasing the risk of damage to healthy tissues. Hence, enhancing the sensitivity and selectivity of RCC in RT is vital [1–3]. Radiosensitizers are a class of molecules or materials that can sensitize cancer cells to RT. Their primary mechanisms include the following: (I) inhibiting the radiation-induced repair of DNA damage or increasing the degree of DNA damage; (II) disrupting the cell cycle and organelle function to improve cytotoxicity; and (III) inhibiting the expression of radiation-resistant genes or promoting the expression of radiation-sensitive genes [4]. Nitroimidazoles are a promising class of oxygen-mimetic radiosensitizers that can mitigate hypoxia-induced radioresistance [5]. The electron-affinic nitro group in the imidazole structure makes it vulnerable to oxygen species radicals induced via ionizing radiation. The resulting radical adducts have much higher reactivity to DNA, leading to DNA strand breaks, self-repair failure, and programmed cell death [6–8]. However, nitroimidazole derivatives often exhibit high uptake and metabolic ratio by livers following administration because of poor water solubility. Consequently, the in vivo drug distribution of nitroimidazoles accumulated in kidneys is much low, limiting the therapeutic outcome [9–11]. Polyethylene glycol (PEG) is a polymer with remarkable water solubility and good biocompatibility [12], and its modification can extend blood circulation time, alter drug pharmacokinetics, and enhance drug bioavailability [13, 14]. PEG modification is a hot research topic in drug design and development [15–17]. Various PEGylated agents are currently used in clinical practice, including PEGylated doxorubicin liposomes, PEGylated irinotecan liposomes, PEG-asparaginase, and PEG-antihemophilic factor [18]. Particularly in the context of the ongoing COVID-19 pandemic, there has been a significant increase in the approval of PEGylated vaccines for marketing purposes [19, 20]. PEGylation has been extensively investigated for the development of anticancer drugs due to its ability to modify physicochemical properties and reduce cytotoxicity, and thereby promote therapeutic efficacy [21, 22]. Moreover, recent reports suggest that PEGylation markedly promotes drug clearance via the renal metabolic pathway, increasing the likelihood of the accumulation of anticancer drugs and their prototypes in RCC cancer cells [23, 24]. Mitochondria are vital subcellular organelles that play a central role in energy production and cell survival. In particular, tumor cell mitochondria have been identified as closely related to cancer metastasis and RT resistance. Thus, the specific delivery of nitroimidazole radiosensitizers to cancer cell mitochondria can significantly improve the RT effect. Recently, a mitochondria-targeting nitroimidazole, 808-NM2, has been identified to preferentially accumulate in tumor cells and effectively inhibit breast tumor growth synergistically via chemotherapy and RT [25]. 808-NM2 was prepared by chemically conjugating nitroimidazoles with a mitochondria-targeting heptamethine cyanine dye (IR-808) which has also been extensively evidenced with tumor-preferential accumulation [26–28]. Although 808-NM2 has the potential to be a radiosensitizer, its application for RCC is hindered by its strong hydrophobicity and low renal accumulation. In this study, the mitochondria-targeted 808-NM2 was modified with different molecular weights of PEG (PEG-550 and PEG-2000), aiming to improve water solubility, enhance RCC accumulation, and radiosensitization. The structures of the newly designed PEG-808-NM2 molecules (PEG550-808-NM2 and PEG2000-808-NM2) are shown in Scheme 1. Unlike 808-NM2, one side chain of PEG-808-NM2 is a long hydrophilic PEG linker, whereas the other side chain is a hydrophobic ending with 2-nitroimidazole. In our design, their amphiphilic and asymmetrical structures are anticipated not only to improve water solubility but also to facilitate self-assembly in aqueous solution to form nanoparticles with small sizes. Recent studies have acknowledged that the size of nanoparticles below 200 nm is more prone to kidney excretion [29]. The preferential accumulation in RCC cells and their mitochondria will further considerably enhance radiosensitization.Scheme 1Schematic illustration of the PEG-modified PEG-808-NM2 and its corresponding anti-tumor effect of radiosensitization. By asymmetrical and amphipathic modification of 808-NM2 (left), the PEG2000-808-NM2 (middle) could self-assemble to form nanoparticles PEG-808-NM2 (right) in aqueous environment and then enhance the preferential accumulation in renal tumors, boosting imaging-guided radiotherapy of renal cell carcinoma by targeting mitochondria Schematic illustration of the PEG-modified PEG-808-NM2 and its corresponding anti-tumor effect of radiosensitization. By asymmetrical and amphipathic modification of 808-NM2 (left), the PEG2000-808-NM2 (middle) could self-assemble to form nanoparticles PEG-808-NM2 (right) in aqueous environment and then enhance the preferential accumulation in renal tumors, boosting imaging-guided radiotherapy of renal cell carcinoma by targeting mitochondria Experimental section Chemicals and materials 2-Nitroimidazole, 1,6-dibromohexane, 2,3,3-trimethylindole, PEG monomethyl ether (PEG-550, PEG-2000), methylene chloride, and methanol were purchased from Adamas. Ethanol, n-hexane, ethyl acetate, toluene, n-butanol, dimethyl sulfoxide (DMSO), and sodium acetate were purchased from Sigma-Aldrich. N,N-dimethylformamide was obtained from Aladdin. All reagents were used directly without further purification. The synthesis of PEG550-808-NM2, PEG2000-808-NM2, and 808-NM2 are described in detail in Supplementary Information. Simulation details and methods In the present work, the aggregation of PEG molecules in water was studied using molecular dynamics simulations. Each simulation box contains five independent PEG2000-808-NM2 molecules, five independent bromine ions and 20000 independent water molecules. Simulations were performed using the Gromacs-2020.7 software package [30] and the molecular force field was performed using CHARM36. [31] The results were visualized using the visualization software VMD [32]. The non-bonding interactions contain van der Waals and electrostatic interactions, both of which have a cut-off radius set to \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$r_{c} = 1.2$$\end{document}rc=1.2 nm. The interaction between particles is expressed using the LJ potential.\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$V_{LJ} = \left\{ {\begin{array}{*{20}c} {4\varepsilon \,\left[ {\left( {\frac{\sigma }{r}} \right)^{12} - \left( {\frac{\sigma }{r}} \right)^{6} } \right]} & {,\,r < r_{c} } \\ {0,} & {,\,r < r_{c} } \\ \end{array} } \right._{c}$$\end{document}VLJ=4εσr12-σr6,r